Want to see TSE:LFST full AI Analyst Report?
Top Page
Lifeist Wellness
(LFST)
Select Model
Select Model
Rating:41Neutral
Price Target:
C$0.04
▼(-36.67% Downside)
Action:Reiterated
Date:09/26/26
The score is held down primarily by very weak financial performance (collapsed revenue, negative margins, persistent cash burn, and a sharply reduced equity base). Technicals also remain bearish with price below key moving averages and negative MACD. Valuation is only a modest offset, with a low P/E that is tempered by weak fundamentals and no dividend support.
Positive Factors
Debt-Free Balance Sheet
Reported zero debt reduces interest obligations and leverage-related pressure, giving the company more flexibility than a similarly weak business carrying substantial borrowings. This cushion could help management redirect scarce resources toward stabilization and portfolio priorities.
Negative Factors
Severe Revenue Contraction
The collapse in revenue indicates a substantial loss of commercial scale and materially weakens the foundation for sustainable earnings. With sales now a small fraction of earlier levels, the company has less ability to absorb fixed costs, support product investment, or rebuild a durable operating platform.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-Free Balance Sheet
Reported zero debt reduces interest obligations and leverage-related pressure, giving the company more flexibility than a similarly weak business carrying substantial borrowings. This cushion could help management redirect scarce resources toward stabilization and portfolio priorities.
Read all positive factors
Lifeist Wellness (LFST) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$1.52M
Dividend YieldN/A
Average Volume (3M)6.49K
Price to Earnings (P/E)9.5
Beta (1Y)0.85
Revenue Growth-87.74%
EPS Growth-220.61%
CountryCA
Employees72
SectorConsumer Defensive
Sector Strength42
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)-0.03
Shares Outstanding37,886,402
10 Day Avg. Volume7,589
30 Day Avg. Volume6,489
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.15
Price to Sales (P/S)9.88
P/FCF Ratio-0.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lifeist Wellness Business Overview & Revenue Model
Company Description
Headquartered in Vancouver, Canada, and established in 2005, Lifeist Wellness Inc. (formerly Namaste Technologies Inc. until September 2021) operates as a multifaceted wellness enterprise across the United States and Canada. Its diverse portfolio ...
How the Company Makes Money
Lifeist generates revenue primarily through sales made by its operating subsidiaries. Key revenue streams have historically included (1) consumer wellness product sales (e.g., plant-based/alternative wellness products sold through wholesale, retai...
Lifeist Wellness Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
42
Neutral
Cash Flow
12
Very Negative
| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 281.14K | 249.37K | 588.80K | 21.66M | 22.07M | 21.15M |
| Gross Profit | -321.93K | -845.37K | 204.75K | 5.34M | 3.79M | 120.29K |
| EBITDA | -1.60M | -2.39M | -3.99M | -5.96M | -17.44M | -20.25M |
| Net Income | 3.86K | -2.99M | -1.45M | -14.13M | -15.44M | -23.80M |
Balance Sheet | ||||||
| Total Assets | 1.14M | 1.84M | 5.13M | 13.40M | 20.67M | 37.96M |
| Cash, Cash Equivalents and Short-Term Investments | 74.15K | 781.81K | 2.34M | 1.45M | 3.80M | 12.74M |
| Total Debt | 0.00 | 0.00 | 0.00 | 1.27M | 328.33K | 554.59K |
| Total Liabilities | 408.67K | 688.62K | 1.06M | 9.94M | 7.30M | 11.89M |
| Stockholders Equity | 730.50K | 1.15M | 4.07M | 3.46M | 13.36M | 26.06M |
Cash Flow | ||||||
| Free Cash Flow | -1.56M | -2.90M | -877.20K | -2.79M | -16.04M | -18.64M |
| Operating Cash Flow | -1.56M | -2.90M | -877.20K | -2.46M | -15.35M | -18.28M |
| Investing Cash Flow | 665.12K | 1.34M | 1.92M | 1.28K | 6.69M | -229.57K |
| Financing Cash Flow | 0.00 | 0.00 | -169.19K | 83.82K | -252.29K | 21.02M |
Lifeist Wellness Technical Analysis
Negative
0.06
Price Trends
0.05
Negative
0.05
Negative
0.05
Negative
Market Momentum
>-0.01
Positive
25.19
Positive
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LFST, the sentiment is Negative. The current price of 0.06 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and above the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 25.19 is Positive, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:LFST.
Lifeist Wellness Peers Comparison
UnderperformOutperform
Sector (62)
TSE:LFST
Lifeist Wellness
0.04
-0.05
-52.94%
TSE:MGW
Maple Leaf Green World
0.03
0.00
0.00%
TSE:TCAN
TransCanna Holdings Inc
0.01
0.00
0.00%
TSE:SILO
Silo Wellness Inc
0.01
0.00
0.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.